AirStrip's mobile patient monitoring applications receive CE Mark

AirStrip Technologies, Inc. has received CE Mark certification to market its innovative mobile patient monitoring applications in the European Community as well as other international territories outside Europe, company officials announced today.

In obtaining the CE Mark, AirStrip Technologies demonstrates that it conforms to international quality benchmarks for medical devices, including ISO standards.

"This is a significant milestone that indicates our FDA-cleared solutions also meet the quality and safety standards required by the international healthcare marketplace," said AirStrip Technologies CEO Alan Portela. "We have seen an incredible level of interest in bringing our applications to Europe and other territories, and we can now aggressively move forward with our expansion plans."

Applications currently available include AirStrip OB^TM, AirStrip CARDIOLOGY^TM and AirStrip PATIENT MONITORING^TM, which are now used by thousands of clinicians at hundreds of US hospitals. The applications give clinicians anytime, anywhere access to vital live and historical patient data including waveforms, ECGs and other information, right on their smartphone or tablet.

AirStrip CARDIOLOGY was just named the best US medical application for the iPhone® as part of App Store Rewind 2011, which collects the year's top apps as selected by the App Store^SM editorial team.

AirStrip also recently announced a partnership with Qualcomm Life Inc., a subsidiary of Qualcomm Incorporated, to develop and execute a home health monitoring initiative that integrates AirStrip solutions into the Qualcomm 2net^TM Platform. The initial focus will be on helping curb hospital readmission rates for congestive heart failure patients.

"We are constantly working to ensure that our applications offer the most productive and reliable user experience possible," said AirStrip Technologies Executive Vice President and Chief Strategy Officer Bruce Brandes. "International commercialization is the exciting next step in expanding the availability of AirStrip's native applications, which enable more timely and accurate diagnosis and treatment and are already in strong demand globally."